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Abstract
Until recently, insufficient attention has been paid to the fact that surgical interventions are complex. This
complexity has several implications, including the way in which surgical interventions are described and delivered
in trials. In order for surgeons to adopt trial findings, interventions need to be described in sufficient detail to
enable accurate replication; however, it may be permissible to allow some aspects to be delivered according to
local practice. Accumulating work in this area has identified the need for general guidance on the design of
surgical interventions in trial protocols and reports. Key issues to consider when designing surgical interventions
include the identification of each surgical intervention and their components, who will deliver the interventions,
and where and how the interventions will be standardised and monitored during the trial. The trial design
(pragmatic and explanatory), comparator and stage of innovation may also influence the extent of detail required.
Thoughtful consideration of surgical interventions in this way may help with the interpretation of trial results and
the adoption of successful interventions into clinical practice.
Keywords: Surgical trials, Trial design, Complex interventions, Methodology, Standardisation, Adherence/fidelity,
Expertise
Background
There has been an increasing recognition over the past
decade that surgical interventions are complex [1–3].
Complex interventions have multiple components,
which can act independently or inter-dependently to
influence outcomes [3]. The components of surgical
interventions may include parts of the operation such
as incising, resecting or closing. Surgical interventions
are accompanied by concomitant interventions that
can occur before, during or after surgery and also have
several components - for example, delivering an
anaesthetic or providing post-operative pain relief.
Contextual factors such as the operating theatre envir-
onment, availability of certain equipment and the sheer
volume of cases undertaken within a hospital can all
influence outcomes and therefore contribute to the
complexity. Finally, complex interventions such as
surgery can be dependent on the skills of those deliv-
ering care (operator expertise), and this may also
influence outcomes [4]. Within randomised controlled
trials (RCTs) of surgical interventions, it is therefore
necessary to consider the surgical and concomitant
interventions, contextual factors and operator expert-
ise, and decide to what extent they need to be
described and standardised within trial protocols [5].
The MRC (Medical Research Council) guidance for
developing and evaluating complex interventions
recommends that centres participating in RCTs ‘con-
sistently provide as close to the same intervention as
possible’ by ‘standardising the content and delivery of
the intervention’. The guidance recommends identify-
ing and piloting the key components of interventions
before full evaluation within RCTs [6–8]. Whilst this
may be helpful advice, how to operationalise this when
designing RCTs in surgery remains unclear. The recent
publication of the SPIRIT statement (Standard Protocol
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Items: Recommendations for Interventional Trials) [9]
provides some guidance for describing interventions
within trial protocols. It recommends that interventions
are ‘described in detail so that they can be replicated in
practice’, and states that details about ‘relevant concomi-
tant care and interventions’ and ‘study settings where data
will be collected’ be provided. Whether this means that
every detail of a surgical operation, anaesthetic and
aftercare should be described in the trial protocol is
unclear. Providing such detailed descriptions may help
to distinguish between the interventions in each trial
group, ensuring that they are actually different from
one another. For this reason, it may also improve
systematic reviews of RCTs of similar surgical interven-
tions. Conversely, however, it is possible that this level
of detail is not always necessary or practical. Within
large scale pragmatic trials, for example, less informa-
tion may be required. Detailed descriptions may also
fail to reflect the inherent variation in clinical practice
and consequently reduce the generalisability of the
results. A balance between ‘adequate’ descriptions of inter-
ventions and the practicality of delivery is necessary. Some
guidance regarding how to go about this process when
designing surgical interventions is needed.
The aim of this paper is to describe the key questions to
consider during the design of an RCT involving surgical
interventions. Issues will be illustrated with examples.
This work arose from a 2-day MRC Hub for Trials
Methodology Research Network workshop held in June
2013 led by the ConDuCT (Collaboration and Innovation
in Difficult Randomised Controlled Trials, Bristol) and
Biostatistics (Cambridge) Hubs.
Review
Designing surgical interventions within RCTs
Questions to consider during the design of surgical
interventions in RCTs are summarised in Table 1, with
an accompanying glossary of terms in Table 2. Each item
in Table 1 is illustrated below using the example of inter-
ventions for appendicitis. This example was chosen
because appendicectomy is a common operation with
several possible technical variations, and there is an estab-
lished non-surgical alternative treatment (treatment with
antibiotics). The questions address i) surgical inter-
ventions (items 1 and 2); ii) concomitant interven-
tions (item 3); iii) how to describe, standardise and
monitor surgical and concomitant interventions (items
4, 5 and 6); iv) operator expertise (item 7); and v)
context (item 8).
Does the RCT involve at least one surgical intervention?
Initially, it is important to decide if the study in question
is a surgical RCT. In this paper, a RCT in surgery is
defined as evaluating a surgical intervention in at least
one of the trial groups. A surgical intervention is
defined as one that involves physically changing body
tissues and organs through manual operation such as
cutting, suturing, abrading or the use of lasers [10].
Surgical interventions may be the main intervention
under investigation or be a concomitant intervention.
An example of the former might be the evaluation of
open versus laparoscopic surgery for the treatment of
appendicitis. Conversely, a trial comparing two different
types of post-operative pain relief following surgery for
appendicitis would represent an example of surgery as a
concomitant intervention (because the main comparison
is between the methods of pain relief rather than surgery).
This paper will focus on issues to consider in the design
of surgical interventions in RCTs in which they are the
main intervention under evaluation. Work investigating
how concomitant surgical interventions might be de-
scribed in trial protocols will be addressed separately.
What are the surgical interventions under evaluation?
A recent systematic review examining reporting stan-
dards for surgical interventions found that 30 % of
trials reported only the name of the intervention
under investigation and gave no further written detail
[11]. Providing just the name of a surgical intervention,
such as ‘appendicectomy’, leaves this open to different
interpretations by different surgeons. It is therefore rec-
ommended that specific details of the intervention be
clarified and agreed at the beginning of a trial, and
described in more detail in trial publications. One way of
achieving this is for the trial team to identify systematically
all of the constituent components and steps of the surgical
intervention during the trial design or pilot work. Exam-
ples of potential components and steps involved in
performing an appendicectomy are described in Table 3.
This identification process should also include any planned
Table 1 Questions to ask during the design of surgical
interventions in randomised controlled trials (RCTs)
Description
1 Does the RCT involve a surgical intervention?
2 What is/are the surgical intervention(s) under evaluation?
3 What is/are the concomitant intervention(s) accompanying surgery?
4 What will influence standardisation of the interventions?
a. What is the overall study design?
b. What type of comparator is in the RCT?
c. In what stage of development is/are the surgical intervention(s)?
5 How will the intervention(s) be standardised in the RCT?
6 How will delivery of the intervention(s) be monitored in the
RCT (fidelity)?
7 Who will deliver the intervention(s) (operator expertise)?
8 Where will the intervention(s) be delivered (context)?
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further operations; for example, elective two-staged
liver resection involves two operations with an inter-
vening interval of between 2 and 6 weeks. It is neces-
sary to clearly state that there is a planned second
operation, as well as the anticipated interval between
the first and second operations.
Systematic documentation of all intervention compo-
nents, from skin incision through to wound closure, would
prevent potentially important aspects of the intervention
from being overlooked. Additionally, the a priori identifica-
tion of intervention details will help the trial team to clarify
which components and/or steps are considered important
to the research question, or the quality assurance of
surgery. It will be essential to document and justify the
extent of standardisation and monitoring required for such
components/steps during the trial (see questions 4 and 5).
What are the concomitant interventions accompanying
the surgical intervention?
Similar to surgical interventions themselves, concomi-
tant interventions often comprise multiple components
and these may require consideration during trial design.
All of the potential concomitant interventions associated
with the surgical intervention may need to be identified
Table 2 Interventions in surgical randomised controlled trials (RCTs): suggested terminology and definitions
Term Definition
Complex intervention An intervention with multiple components that act inter-dependently or independently to influence outcomes [6].
Surgical intervention An intervention that cuts or physically alters a patient’s tissues (whether using a scalpel, stapler, laser or another instrument or
device) and involves the use of a sterile environment, anaesthesia, antiseptic conditions and suturing or stapling [10].
Concomitant intervention
(or co-intervention)
Interventions that naturally accompany or are associated with the intervention itself [22]. Concomitant interventions can occur
before, during or after the main intervention.
Context The distinctive features of an intervention’s setting, participants and delivery [23].
Expertise The ability to integrate technical and non-technical skills to complete challenging tasks.
Fidelity How far those responsible for delivering an intervention actually adhere to the intervention as it is outlined by its designers [24].
Fidelity is also referred to as compliance or adherence.
Pragmatic trial A trial which is designed to answer the question ‘How well does the intervention work in comparison to the control when
delivered under usual conditions?’ [25] (that is, effectiveness focused, usually aiming to influence health policy)
Explanatory trial A trial that is designed to answer the question ‘How well does the intervention work in comparison to the control when delivered
under ideal conditions?’ [25] (that is, efficacy focused, usually aiming to investigate the causal relationship between an intervention
and physiological processes)
Table 3 Examples of the steps within a surgical intervention: appendicectomy
Components Definition Description Steps within each component
Two further 0.5-cm incisions in the left iliac
fossa and suprapubic regions.
Separation and incision of
the fat, fascia, muscular
layers and peritoneum.
Identification of the base of the umbilicus.
Incision of fascia using a knife and peritoneum
using scissors.
Creation of a
pneumoperitoneum
Insertion of the laparoscopic ports (through
fascia and peritoneum).
Insufflation of gas into the abdomen.
Dissection of the appendix The process of exposing
an organ, tissue or structure
Dissection of tissues
surrounding the appendix.
Use of a laparoscopic hook and diathermy to
dissect the appendix from surrounding tissues.
Isolation and ligation of
the blood supply.
Use of hook diathermy to divide the
mesoappendix and coagulate the artery.
Resection of the appendix Removal of all or part of
an organ, tissue, or structure
Securing the appendix
base with staples/sutures.
Application of sutures to the base of the
appendix.
Division of the base of the
appendix.
Cutting of the appendix from its base with
laparoscopic scissors.
Removal of the appendix
from theabdomen.
Placement of a bag into the abdomen within
which to retrieve the appendix through a
laparoscopic port.
Closure of the abdomen Closure of the abdominal
layers
Closure of the peritoneum,
fascia and skin.
Closure of the fascia at the umbilical port site
using a box stitch. Closure of the skin at all
three port sites, using sutures or steri-strips.
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and listed during trial team meetings during the design
phase (Table 4). Subsequently, the ‘key’ concomitant
interventions (and their components) can be detailed
within the trial protocol. This may include discussions
about which of the concomitant interventions need to be
standardised across all trial groups. Factors influencing
the level of detail required are discussed below.
What will influence the amount of standardisation
needed for the intervention?
Key questions to consider are illustrated with published
examples in Table 5.
What is the overall trial design?
The overall design and purpose of the trial will influ-
ence the extent to which interventions are standar-
dised. Explanatory trials (defined in Table 2), which
determine the efficacy of interventions, are likely to
require detailed intervention descriptions and strict
standardisation of delivery. Because explanatory trials
often involve just a few centres or surgeons, tend to
have a less varied patient cohort, and may be conducted
by the surgeons responsible for developing the novel
procedure, this may be possible to achieve. Conversely,
pragmatic designs (defined in Table 2) determine whether
interventions are effective in a more general setting, and
therefore usually involve large numbers of surgeons and
centres. Under such circumstances, ensuring tight control
over intervention delivery is likely to be difficult and may
be undesirable given the pragmatic design. Although a less
detailed description of the intervention may be required
in the trial protocol, those components that are consid-
ered to be ‘key’, or those that are crucial in distinguishing
the interventions between trial groups, should be reported
as a minimum.
What type of comparator is in the study?
It is important to establish how the surgical intervention
under investigation is different to treatment within the
other trial groups. For example, in a trial comparing a
surgical and non-surgical intervention (surgery versus
antibiotics for appendicitis), a detailed description of the
operation may not be required because the key difference
between the interventions are immediately apparent. In a
trial comparing two perations for appendicitis (for ex-
ample, laparoscopic and single-port appendicectomy),
Table 4 Examples of concomitant interventions accompanying a surgical intervention: knee replacement
Pre-, peri- or post-operative Concomitant interventions Description
Pre-operative Magnetic resonance imaging Pre-operative imaging to plan the exact type
of implant required
Investigations within the pre-operative
assessment clinic
Pre-operative blood tests, electrocardiogram,
X-rays and other interventions
(such as echocardiogram) as required
Physiotherapy Muscle strengthening exercises
Peri-operative Application of pulse oximeter, oxygen
mask and blood pressure cuff
Intra-operative monitoring devices
Application of continuous pump devices
and compression stockings
Preventative measures for deep vein
thrombosis
Insertion of a urinary catheter To prevent urinary retention (potential
consequence of spinal anaesthesia)
Insertion of a peripheral cannula To allow delivery of intravenous analgesia
Administration of spinal anaesthesia Injection of a local anaesthetic into the
subarachnoid space, through a fine needle
Administration of intravenous analgesia To minimise intra-operative pain
Application of a knee bandage To provide pressure and minimise swelling
Post-operative Administration of subcutaneous clexane Preventative measures for deep vein
thrombosis
Application of continuous pump devices
and compression stockings
Preventative measures for deep vein
thrombosis
Administration of oral analgesia To minimise post-operative pain
Physiotherapy Muscle strengthening exercises
and learning to walk with crutches
or a frame
Use of a continuous passive movement
machine
Provide passive motion in a specific
plane of movement, and protect the
healing repair or tissue
Blencowe et al. Trials  (2015) 16:392 Page 4 of 9
the interventions are more similar to each other. It may
therefore be important to clarify the expected differ-
ences in intervention delivery between the two groups
(for example, the number and size of laparoscopic
ports), to describe these in the protocol and monitor
their delivery during the trial.
What stage of development is the intervention?
The stage of development of an intervention may
influence the amount of detail required in the trial
protocol. The IDEAL (Idea-Development-Exploration-
Assessment-Long term study) guidance provides a
framework for the staged development and evaluation
of novel surgical interventions [1–3]. In stage 2b, pilot
work is recommended prior to rolling out an effective-
ness trial because the intervention may be still evolv-
ing. In this type of pilot study it is likely that extensive
detail regarding the intervention needs to be documented
and strict standardisation of the intervention man-
dated, along with explicit reporting of any changes
implemented and the rationale behind them. In
IDEAL Stage 3 RCTs, the extent to which interven-
tions need to be described and standardised may
depend more upon the overall trial design (pragmatic
versus explanatory approaches - see above).
How will the intervention(s) be standardised in the RCT?
Standardisation of surgical interventions relates to the
extent to which trial protocols specify exactly how they
should be delivered. Several factors may influence the
amount of standardisation that may be required, such as
the overall trial design and research objective, and these
are considered in question 4. The process of deciding
how much standardisation is necessary starts during trial
design, with the trial team identifying all of the con-
stituent components and steps of each intervention
(questions 2 and 3). Once the components and steps
have been listed, details about exactly how they should
be performed can be established. For example, trialists
can decide whether each of the components and steps
are mandatory, prohibited or optional [12, 13]. Subse-
quently, they can consider whether the components
and steps should be performed in a specific way, or
flexibly (that is, according to individual surgeon prefer-
ences). An example of a trial in which standardisation
of the surgical interventions was unclear, subsequently
leading to a published debate, is provided in Table 6.
It may be very difficult to standardise completely the
‘form’ of complex interventions such as surgery - that is,
all of the components. One potential compromise would
be to standardise an intervention’s key ‘functions’ rather
than specifying the specific ‘form’ it needs to take.
Standardisation of surgical interventions in trial proto-
cols may, therefore, range from completely flexible deliv-
ery of the entire intervention to rigid standardisation of
every step. In appendicectomy, for example, it may sim-
ply be stated that the appendix be removed (that is,
standardisation of ‘function’ only), meaning this can be
Table 5 Examples of published randomised controlled trials (RCTs) in surgery requiring different amounts of standardisation of
the interventions
Factors contributing to the level of
control required
Example of RCTs requiring less standardisation Example of RCTs requiring more standardisation
Scope of the trial Comparison of surgery and medical therapy for
treatment of gastro-oesophageal reflux disease [26]
Carotid artery stenting compared with endarterectomy
in patients with carotid stenosis [27]
Pragmatic versus explanatory approach
to design
Pragmatic: The trial aimed to establish the
effectiveness of the interventions in practice
Explanatory: The trial aimed to establish the safety and
efficacy of the ‘new’ intervention (stenting) under ideal
conditions
Stage of innovation of the intervention Open versus minimally invasive surgery for
colorectal cancer [28]
Endovascular versus open repair of abdominal aortic
aneurysms [29]
Established versus new innovation Established: Open colorectal surgery is routinely
undertaken by many operators in clinical practice
and the main steps are already known
Early: Endovascular aneurysm repair is a relatively new
technique and the main steps are less well known
Complexity of the intervention Effect of an implantable gentamicin-collagen
sponge on sternal wound infections following cardiac
surgery [30]
Extracranial-intracranial bypass surgery for stroke
prevention in hemodynamic cerebral ischemia [31]
Few components and low technical
difficulty versus multiple components
or requiring highly complex skills
Low complexity: Intervention involves placing an
antibiotic impregnated sponge beneath patients’
wounds prior to closure
High complexity: Intervention is complex involving
multiple components, high levels of technical
expertise and multiple concomitant interventions
Nature of interventions being compared Amoxicillin plus clavulanic acid versus
appendicectomy for treatment of acute
uncomplicated appendicitis [32]
Laparoscopic gastric bypass versus laparoscopic
duodenal switch for super obesity [33]
Surgical and non-surgical intervention,
or different surgical interventions
Surgery versus non-surgery: Distinction between
trial groups is straightforward because of the very
different nature of interventions
Surgery versus surgery: Distinction between the two
groups is less straightforward because both
interventions are surgical
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performed with robotic or minimal access techniques, or
using an open incision. Even if complete flexibility is
allowed, this should be stated explicitly to avoid doubt.
The other extreme - where an intervention is rigidly
standardised in a trial - requires extensive details to be
provided within the trial protocol. This would include
information about each of the mandatory, optional and
prohibited components and steps of the intervention
(that is, standardisation of ‘function’ and ‘form’) and
delivery of these would be monitored strictly during the
trial itself.
Will intervention delivery be monitored during the trial?
If so, how?
During a trial, it may be necessary to assess whether the
intervention was delivered as intended (fidelity). Fidelity
has been defined as ‘how far those responsible for deliv-
ering an intervention actually adhere to the intervention
as it is outlined by its designers’ [14]. The degree to
which intervention fidelity needs to be monitored within
RCTs will largely depend upon the extent to which the
trial protocol prescribes standardisation. For example, if
it is decided that certain components or steps of an
operation are essential, monitoring of these components
to see if they are delivered as planned will be important.
In addition, it may be necessary to monitor whether
prohibited steps were performed in error during the trial.
Assessing whether key components of an intervention are
actually performed according to protocol can be challen-
ging and may require video or photographic evidence,
direct observation or surgeon-reported descriptions of what
was done [11]. If fidelity is found to be lacking within a trial
taking an explanatory approach, active steps might be taken
to improve this including additional training or withdrawal
of surgeons. Conversely, in trials with a more flexible proto-
col, monitoring of the delivery of interventions may not be
required, particularly if the trial protocol clearly states that
these steps can be carried out according to surgeons’
preferred techniques. One limitation of this pragmatic
approach would be the potential loss of documentation of
fidelity, which can be helpful in summarising the range of
techniques used and in interpretation of trial results.
Who will deliver the interventions?
Surgical interventions are not usually delivered by a
single surgeon working in isolation. Instead, they are
typically supported by one or more surgeon colleagues
and a surgical team (for example, nurses and anaesthetists).
The skills of all these team members may influence
treatment outcomes, and it may be necessary to
account for them in RCTs evaluating surgical inter-
ventions, both at the design and analysis stage [15].
Some surgical interventions may be more dependent
on particular expertise than others (see question 4),
and a discussion of these issues during trial design is
recommended. If the delivery of a surgical interven-
tion is considered to be heavily dependent on expert-
ise, or requires a step-change in technical skill, it may
be necessary to set pre-defined entry criteria for
surgeons such as a minimum annual caseload, attend-
ance of training courses, number of years in training,
or outcome data thresholds [11]. Alternatively, it may
be possible to account for expertise within trial design
using expertise-based RCTs [16] or the detection and
modelling of learning curves [17]. In other circumstances,
for example more pragmatic trial designs, formal minimal
criteria for surgeons’ expertise beyond what is required in
routine practice may be of limited value. This is conten-
tious, however, as some consider that trials should never
involve ‘novice’ surgeons who are still learning techniques,
irrespective of the overall design, because the results may
be interpreted as less convincing.
Table 6 An example of a surgical randomised controlled trial (RCT) in which the surgical interventions were questioned following
publication of the trial
Trial features
Journal, year of publication Lancet, 2009
Aim of RCT To compare survival between standard or minimally invasive surgery in patients with colorectal cancer [28].
Main findings The survival rate following minimally invasive surgery was non-inferior to standard surgery
Verbatim description of the surgical
intervention
The following description was provided for both open and minimally invasive surgery: ‘Resection involved the
division of blood vessels and bowel’. Conversion to open surgery was defined as a ‘vertical incision’. No other
description regarding the incisions was provided.
Published correspondence ‘What about right-sided cancers? It is well known among laparoscopic surgeons that ‘laparoscopic’ right colectomy
can in fact mean three different kinds of procedures: a true or totally laparoscopic right colectomy (with
both dissection and anastomosis done intra-corporeally), laparoscopically assisted colectomy (with only
the vascular ligation done intra-corporeally), or so-called laparoscopic colectomy (with only the colonic
dissection done laparoscopically). The authors of the CLASICC trial stated only that resection involved
‘(where possible) the division of blood vessels and bowel’. Conversion was defined as a ‘vertical incision’,
but what about (for example) a transverse incision of almost 7 cm in a thin patient allowing both division
of vessels and bowel after a simple laparoscopic colonic mobilisation? Is that procedure laparoscopic or
open? Since the actual procedure is not specified, the external validity of trials regarding the laparoscopic
approach for right-sided colon cancers should be questioned [34].’
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Where will the interventions be delivered?
Context can be defined as the distinctive features of an
intervention’s setting, participants and delivery [18]. In
surgical RCTs, this may include the type of hospital and
department (for example, tertiary centre versus district
general hospital) as well as features of the surgical teams
(for example, specialists versus generalists). Whilst
context may be more relevant in some RCTs than others
(see question 4), it is recommended that all trials
consider and describe whether there are any elements of
context that were important for the delivery of the trial
or that may have had an impact on the effect of the
intervention. In some circumstances, it may be neces-
sary to set pre-defined criteria regarding context, such
as centre volume or constituent members of the multi-
disciplinary team responsible for delivering the surgical
interventions.
Discussion
This paper identifies key questions relevant to the design
and reporting of surgical interventions in RCTs in
surgery. The questions cover issues relating to interven-
tion description, standardisation and monitoring, expert-
ise of surgical teams, and the context of intervention
delivery. Consideration of these issues is recommended
so that appropriate levels of detail about interventions,
and methods for monitoring their delivery, can be docu-
mented in the trial protocol and can be subsequently
assessed during the trial itself. This may go some way to
reduce the criticisms currently levelled at the heteroge-
neous delivery of interventions within RCTs in surgery.
Since the workshop in which these issues were discussed
took place, the TIDieR (Template for Intervention
Description and Replication) checklist has been pub-
lished [19]. TIDieR provides guidance for describing
interventions within RCTs, recommending that infor-
mation other than just the name of the intervention
be reported. The authors state that ‘the overarching
purpose of the TIDieR checklist is to prompt authors
to describe interventions in sufficient detail to allow
their replication’. Items within TIDieR include consid-
eration of the processes involved in the intervention,
the mode of delivery and any context and expertise
requirements. Although these items are helpful in
surgical settings, TIDieR is not specific to a particular
intervention type. This means that some of the checklist
items may be less relevant to surgery, for example, inter-
vention duration, dose and the number of times delivered.
Additionally, there may be important omissions for
describing complex interventions. For example, TIDieR
does not include concomitant interventions that may be
particularly relevant for interventions such as surgery.
Although the guidance states that interventions should be
described in sufficient detail to allow replication, it does
not discuss potential circumstances that may remove the
need for such in-depth information, such as study design
(for example, pragmatic versus explanatory approach) or
the stage of innovation of the intervention (for example,
‘established versus ‘new’ procedures).
This paper recommends that trialists list all the
components and steps of surgical interventions in a
thorough and logical way, and then identify which
components need to be standardised. It does not,
however, explore how the key components might be
identified if they are not obvious after all of the inter-
vention components and steps have been listed.
Whilst this can be informed by discussion and meet-
ings, it is an area that needs further work. There are
several potential methods for determining the key
components of surgical interventions. These include
surveys of literature and current practice, consensus
methods to reach agreement between stakeholders,
the use of process evaluations or a combination of all
three. To date, however, there has been limited report-
ing of these methods in surgical settings and further
research is required to ascertain their applicability and
relevance [20, 21].
Conclusions
Randomised controlled trials in surgery can be difficult to
design and conduct, and one of the reasons for this is that
surgical interventions are complex. This complexity needs
to be accounted for during trial design by considering
how surgical interventions might be described, standar-
dised and monitored. This paper provides practical guid-
ance for surgeons and trialists to use when designing
interventions in surgical RCTs to aid them in this process,
so this information can be included a priori within trial
protocols. This may help with the interpretation of trial
results and the adoption of successful interventions into
clinical practice. It is now necessary to test this guidance
during the design phases of new surgical trials to assess its
usability, usefulness and acceptability.
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